San Diego (KUSI) – In a anticipated announcement, Pfizer announced on Monday in a Phase 2/3 trial that the Covid-19 vaccine is safe and shows a “strong” antibody response in children ages 5-11. Said showed.
CNN report “These are the first such results published in this age group for the US Covid-19 vaccine, and the data have not yet been peer-reviewed or published. Pfizer has released US Food for Emergency Use Authorization. He said he would submit it to the Drug Administration shortly. FDA officials said that once the data were submitted, the FDA could approve a vaccine for infants within a few weeks. “
In addition, “The study included 2,268 participants aged 5 to 11 years and used a two-dose regimen of the vaccine given at 21-day intervals. The study used a dose of 10 micrograms. This is less than the 30 microgram dose used for people over the age of 12. “
Dr. Christian Lamaze of the Family Health Center in San Diego discussed KUSI’s Good evening results in San Diego.
Dr. Christian Ramers on study that found children ages 5-11 can now get the Pfizer COVID-19 vaccine – Source link Dr. Christian Ramers on study that found children ages 5-11 can now get the Pfizer COVID-19 vaccine –